Immunotherapy’s cardiac effects require early monitoring, managementFebruary 5, 2019DVT & Pulmonary Embolism
COPD linked to higher in-hospital death rates in patients with PADJanuary 22, 2019PAD and ClaudicationDVT & Pulmonary Embolism
ATTRACT trial shouldn’t detract from pharmacomechanical thrombolysisJanuary 14, 2019DVT & Pulmonary EmbolismVenous DiseasesStroke
Large cohort study IDs prognostic factors in thromboangiitis obliteransDecember 5, 2018Mixed TopicsPAD and ClaudicationDVT & Pulmonary EmbolismVenous Diseases
VTE risk may be high throughout disease course in uterine serous carcinomaOctober 23, 2018DVT & Pulmonary Embolism
Rivaroxaban gains indication for prevention of major cardiovascular events in CAD/PADOctober 12, 2018StrokeDVT & Pulmonary EmbolismPAD and Claudication
Expert panel updates guidelines on antithrombotic therapy for AFSeptember 18, 2018DVT & Pulmonary Embolism
New look at ATLAS suggests rivaroxaban may still have role in ACSJuly 2, 2018StrokeDVT & Pulmonary Embolism
